01 10Yervoy
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 1,682
2019 Revenue in Millions : 1,489
Growth (%) : 13
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 2,026
2020 Revenue in Millions : 1,682
Growth (%) : 20
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 2,131
2021 Revenue in Millions : 2,026
Growth (%) : 5
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 2,238
2022 Revenue in Millions : 2,131
Growth (%) : 5
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 36.30%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 1,308
2014 Revenue in Millions : 1,126
Growth (%) : -14%
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 1,244
2016 Revenue in Millions : 1,053
Growth (%) : 18
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 1,053
2015 Revenue in Millions : 1,126
Growth (%) : -6
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 1,330
2017 Revenue in Millions : 1,244
Growth (%) : 7%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 1,489
2018 Revenue in Millions : 1,330
Growth (%) : 12
LOOKING FOR A SUPPLIER?
